# Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

> **NCT01611116** · PHASE2 · COMPLETED · sponsor: **Goethe University** · enrollment: 33 (actual)

## Conditions studied

- Acute Myeloblastic Leukemia

## Interventions

- **DRUG:** sodium chloride solution 0.9%
- **DRUG:** temsirolimus

## Key facts

- **NCT ID:** NCT01611116
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2017-04-26
- **Final completion:** 2017-04-26
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611116, "Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01611116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*